2019-13169. National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Silvio O. Conte Digestive Diseases Research Core Centers.

    Date: July 22, 2019.

    Time: 8:30 a.m. to 6:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.

    Contact Person: Thomas A. Tatham, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK National Institutes of Health, Room 7021, 6707 Democracy Boulevard, Bethesda, MD, 20892-5452 (301) 594-3993, tathamt@mail.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK Clinical Centers Review.

    Date: July 23, 2019.

    Time: 9:00 a.m. to 2:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).

    Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK National Institutes of Health, Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892-2542 (301) 594-8886 sanoviche@mail.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases, Special Emphasis Panel; NIDDK Phase II Clinical Trial SBIR.Start Printed Page 29222

    Date: July 23, 2019.

    Time: 1:00 p.m. to 3:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).

    Contact Person: Thomas A. Tatham, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK National Institutes of Health, Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892-5452 (301) 594-3993, tathamt@mail.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases, Special Emphasis Panel; PAR-18-108: NIDDK Exploratory Clinical Trials for Small Business (R44).

    Date: July 24, 2019.

    Time: 11:30 a.m. to 1:30 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).

    Contact Person: Ann A. Jerkins, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK National Institutes of Health, Room 7119, 6707 Democracy Boulevard, Bethesda, MD, 20892-5452 (301) 594-2242, jerkinsa@niddk.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

    Start Signature

    Dated: June 17, 2019.

    Melanie J. Pantoja,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2019-13169 Filed 6-20-19; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
06/21/2019
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2019-13169
Dates:
July 22, 2019.
Pages:
29221-29222 (2 pages)
PDF File:
2019-13169.pdf